Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection.
Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.
Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection.
HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients.
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.
Production of HIV-1-based virus-like particles for vaccination: achievements and limits.
CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.